Skip to main content
. 2021 May 24;36(4):713–726. doi: 10.1007/s10557-021-07186-y

Fig. 1.

Fig. 1

The workflow of the network pharmacology strategies for determining the pharmacological mechanisms of the SGLT2 inhibitors in diabetes with heart failure through cluster and pathway analysis.